Opioid Use Disorder Clinical Trials in Salt Lake City, Utah

4 studies are recruiting for opioid use disorder in Salt Lake City, Utah right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder

    VA-BRAVE will determine whether a 28-day long-acting injectable sub-cutaneous formulation of buprenorphine at a target dose of 300 milligrams (mg) is superior in retaining Veterans in opioid treatment and in sustaining opioid abstinence compared to the daily sublingual (under the tongue) buprenorph…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, Utah
    Locations
    25 in total
    Run by
    VA Office of Research and Development
  2. Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

    The primary objective of this research study is to evaluate the effect of tirzepatide, relative to placebo, as an adjunct to BUP on retention, substance use, and sleep outcomes in individuals with OUD.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Utah, Salt Lake City, Utah
    Locations
    9 in total
    Run by
    T. John Winhusen, PhD
  3. Standard Versus High Dose ED-Initiated Buprenorphine Induction

    This study is a multisite double-blind, double-dummy, randomized clinical trial enrolling ED patients with untreated moderate to severe opioid use disorder (OUD) to compare Standard Dose Induction (SDI) and High Dose Induction (HDI) on rates of participation in OUD treatment within 10 days post ran…

    Stage
    Phase 3
    Ages
    18 to 65
    Site
    University of Utah Hospital, Salt Lake City, Utah
    Locations
    5 in total
    Run by
    Yale University
  4. Ketamine Assisted Psychotherapy for Opioid Use Disorder

    This pilot clinical trial aims to assess the preliminary efficacy of ketamine as an adjunct for a mindfulness-based intervention for opioid use disorder.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Center on Mindfulness and Integrative Health Intervention Development, Salt Lake City, Utah
    Run by
    University of Utah

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.